Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi

suck pdf from helios


suck pdf from google scholar
unlimited free pdf from europmc32344056    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32344056  :  Publisher
PDF vom PMID32344056
PDF vom PMID32344056

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • Eosinophil responses during COVID-19 infections and coronavirus vaccination #MMPMID32344056
  • Lindsley AW; Schwartz JT; Rothenberg ME
  • J Allergy Clin Immunol 2020[Jul]; 146 (1): 1-7 PMID32344056show ga
  • Eosinophils are circulating and tissue-resident leukocytes that have potent proinflammatory effects in a number of diseases. Recently, eosinophils have been shown to have various other functions, including immunoregulation and antiviral activity. Eosinophil levels vary dramatically in a number of clinical settings, especially following eosinophil-targeted therapy, which is now available to selectively deplete these cells. There are key coronavirus disease 2019 (COVID-19)-related questions concerning eosinophils whose answers affect recommended prevention and care. First, do patients with eosinophilia-associated diseases have an altered course of COVID-19? Second, do patients with eosinopenia (now intentionally induced by biological drugs) have unique COVID-19 susceptibility and/or disease course? This is a particularly relevant question because eosinopenia is associated with acute respiratory deterioration during infection with the severe acute respiratory syndrome coronavirus 2, the causative agent of COVID-19. Third, do eosinophils contribute to the lung pathology induced during COVID-19 and will they contribute to immunopotentiation potentially associated with emerging COVID-19 vaccines? Herein, we address these timely questions and project considerations during the emerging COVID-19 pandemic.
  • |Animals[MESH]
  • |Betacoronavirus/*immunology[MESH]
  • |Coronavirus Infections/*immunology/*prevention & control[MESH]
  • |Eosinophils/*immunology[MESH]
  • |Humans[MESH]
  • |Pandemics/*prevention & control[MESH]
  • |Pneumonia, Viral/*immunology/*prevention & control[MESH]
  • |Viral Vaccines/*immunology[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    1 1.146 2020